MYX 4.96% $3.83 mayne pharma group limited

Are we at the bottom, page-169

  1. 6,939 Posts.
    lightbulb Created with Sketch. 431
    All good.
    It will be a game changer in its segment of the market with many consequences .....
    Can't imagine how menopause market will change if and when E4 gets in there.
    All MYX shareholders can start dreaming of that and its effect on the stock and on their holdings.

    As per the research report, the size of the North America Hormone Replacement Therapy Market Size is valued at USD 6.77 billion in 2020 and is predicted to reach USD 9.55 billion by 2025, growing at a CAGR of 7.12% during the forecast period 2020-2025.
    Add to that 5 billion plus OCP market there.
    so comes to total
    20 billion AUD
    Last edited by Chartsshout: 02/04/21
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.